Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic fatty liver disease

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Frades, Itziar ^a,b   Andreasson, Erik ^b   Mato, Jose Maria ^a   Alexandersson, Erik ^b   Matthiesen, Rune ^c   Martínez Chantar, M Luz ^a  

^a CIC BIOGUNE   (Spain)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; FGF20 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; LIM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SIGNAL PEPTIDE; TGFB1I1 PROTEIN, HUMAN;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FATE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROGNOSIS; PROMOTER REGION; REPRODUCIBILITY; RISK FACTOR; SURVIVAL TIME; ANIMAL; GENETICS; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FIBROBLAST GROWTH FACTORS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; LIVER; LIVER NEOPLASMS; MICE; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RISK FACTORS;

EID: 84930666013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124544     Document Type: Article

References (74)

1. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Seminars in Liver Disease. 2008; 28(4):370-9. doi: 10.1055/s-0028-1091981 PMID: 18956293
2. Day CP, James OFW. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998; 114:842-5. PMID: 9547102
3. Copaci Ionel, Micu Laurentiu, Voiculescu M. The Role of Cytokines in Non-Alcoholic Steatohepatitis. A Systematic Review. J Gastrointestin Liver Dis. 2006 15(4):363-73. PMID: 17205149
4. de Visser K, Eichten A, Coussens L. Paradoxical roles of the immune system during cancer development. Nature Reviews Cancer. 2006 6(1):24-37. PMID: 16397525
5. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004 40(3):667-76. PMID: 15349906
6. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006 439(7074):353-7. PMID: 16273092
7. Parkin DM. The global health burden of infection-associated cancers in the year 2002. International Journal of Cancer. 2006 118.
8. Parkin DM. Tobacco-attributable cancer burden in the UK in 2010. British Journal of Cancer. 2011 Suppl 2: . doi: 10.1038/bjc.2011.489 PMID: 22158327
9. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al. Preventable exposures associated with human cancers. Journal of the National Cancer Institute. 2011 103.
10. La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. European Journal of Cancer Prevention. 1998 4.
11. Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology. 2012 56.
12. Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, et al. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One. 2011; 6.
13. Stickel F, Hellerbrand C. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut. 2010; 59.
14. Jinjuvadia R, Patel S, Liangpunsakul S. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. Journal of Clinical Gastroenterology. 2014 48.
15. Turati F, Galeone C, Rota M, Pelucchi C, Negri E, Bagnardi V, et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Annals of Oncology. 2014
16. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proceedings of the Nutrition Society. 2008 67.
17. Martínez-Chantar ML, Vázquez-Chantada M, Ariz U, Martínez N, Varela M, Luka Z, et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology. 2008.
18. Varela-Rey M, Martínez-López N, Fernández-Ramos D, Embade N, Calvisi DF, Woodhoo A, et al. Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide. Hepatology. 2010 52.
19. Lu SC, Alvarez L, Huang ZZ, Chen LY, An W, Corrales FJ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proceedings of the National Academy of Sciences of the United States of America. 2001 98.
20. Park PJ, Pagano M, Bonetti M. A nonparametric scoring algorithm for identifying informative genes from microarray data. Pacific Symposium on Biocomputing2001.
21. Niehrs C, Pollet N. Synexpression groups in eukaryotes. Nature. 1999; 402(6761):483-7. PMID: 10591207
22. Yu JX, Sieuwerts AM, Zhang Y, Martens JW, Smid M, Klijn JG, et al. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer. 2007; 7:182. PMID: 17894856
23. Dunne K, Cunninghamy P, Azuajez F. Solutions to Instability Problems with Sequential Wrapper-based Approaches to Feature Selection. The Journal of Machine Learning Research. 2002.
24. Rubio A, Guruceaga E, Vázquez-Chantada M, Sandoval J, Martínez-Cruz LA, Segura V, et al. Identification of a gene-pathway associated with non-alcoholic steatohepatitis. Journal of Hepatology. 2007; 46(4):708-18. PMID: 17275126
25. Ye Q, Qin L, Forgues M, He P, Kim J, Peng A, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nature Medicine. 2003; 4:416-23. PMID: 12640447
26. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4:249-64. PMID: 12925520
27. Ding C, Peng H. Minimum Redundancy Feature Selection from Microarray Gene Expression Data. Journal of Bioinformatics and Computational Biology2003.
28. Yang K, Cai Z, Li J, Lin G. A stable gene selection in microarray data analysis. BMC Bioinformatics 2006 7:228. PMID: 16643657
29. Pavel K. Feature selection: stability, algorithms, and evaluation [PhD]. Prage: Czech Technical University in Prague; 2008.
30. Kalousis A, Prados J, Hilario M. Stability of feature selection algorithms: a study on high-dimensional spaces. Knowledge and Information Systems. 2006; 12(1):95-116.
31. Hamming RW. Error Detecting and Error Correcting Codes. Bell System Technical Journal. 1950; 26 (2):147-60.
32. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research. 2010; 38: D355-D60. doi: 10.1093/nar/gkp896 PMID: 19880382
33. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S., Katayama T, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Research. 2006; 34:D354-7. PMID: 16381885
34. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research. 2000; 28:27-30. PMID: 10592173
35. Zharkikh A, Li WH. Statistical properties of bootstrap estimationof phylogenetic variability from nucleotide sequences. I. Four taxa with a molecular clock. Mol Biol Evol. 1992; 6(9):1119-47.
36. Felsenstein J, Kishino H. Is there something wrong with the bootstrap on phylogenies? A reply to Hillis and Bull. Syst Biol. 1993; 42:193-200.
37. Hillis D, Bull J. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst Biol. 1993; 2(42):182-92.
38. Efron B, Halloran E, Holmes S. Bootstrap confidence levels for phylogenetic trees. ProcNatl Acad Sci. 1996; 23(93):13429-34. PMID: 8917608
39. Sanderson MJ, Wojciechwski MF. Improved bootstrap confidence limits in large-scale phylogenies, with an example from Neo-Astragalus (Leguminosae). Syst Biol. 2000; 4(49):671-85. PMID: 12116433
40. Shimodaira H. An approximately unbiased test of phylogenetic tree selection. Syst Biol. 2002; 3 (51):492-508. PMID: 12079646
41. Shimodaira H. Approximately unbiased tests of regions using multistepmultiscale bootstrap resampling. Ann Stat. 2004; 32:2616-41.
42. Suzuki R, Shimodaira H. An application of multiscale bootstrap resampling to hierar-chical clustering of microarray data: How accurate are these clusters? The Fifteenth International Conference on Genome Informatics2004.
43. Suzuki R, Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics. 2006; 22:1540-2. PMID: 16595560
44. Sayers EW, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Reseaserch. 2008
45. Huang S, Fulton D, Arenillas DJ, Perco P, Ho Sui SJ, Mortimer JR, et al. Identification of over-represented combinations of transcription factor binding sites in sets of co-expressed genes. Advances in Bioinformatics and Computational Biology. 3:P247-56.
46. De Preter K, Barriot R, Speleman F, Vandesompele J, Moreau Y. Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions. Nucleic Acids Res. 2008; 36(7):43.
47. Vinciguerra M, Veyrat-Durebex C, Moukil MA, Rubbia-Brandt L, Rohner-Jeanrenaud F, Foti M. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism. Gastroenterology. 2008 1(134):268-80. doi: 10.1053/j.gastro.2007.10.010 PMID: 18166358
48. Li G, Han C, Xu L, Wu T. The role of cyclooxygenase-2 in the development of steatohepatitis. The Federation of American Societies for Experimental Biology Journal. 2009; 23:117.
49. Schadinger SE, Bucher NL, Schreiber BM, Farmer SR. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. American Journal of Physiology - Endocrinology and Metabolism 2005 6(288):E1195-205.
50. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. Journal of Biological Chemistry. 2003 1(278):498-505. PMID: 12401792
51. Lee YJ, Ko EH, Kim JE, Kim E, Lee H, Cho iH, et al. Nuclear receptor PPARaγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proceedings of the National Academy of Sciences U S A. 2012 34(109):13656-61. doi: 10.1073/pnas.1203218109 PMID: 22869740
52. Shiota G. Role of retinoic acid receptor in steatohepatitis-related tumor formation. Journal of Gastroenterology and Hepatology. 2007 S101-7.
53. Videla LA, Rodrigo R, Araya J, Poniachik J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radical Biology & Medicine. 2004 9(37):1499-507.
54. Donato MT, Lahoz A, Jiménez N, Pérez G, Serralta A, Mir J, et al. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts. Drug Metab Dispos. 2006 9(34):1556-62. PMID: 16763015
55. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clinica Chimica Acta. 2003; 1(333):19-39. PMID: 12809732
56. Jover R, Bort R, Gómez-Lechón MJ, Castell JV. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology. 2001; 3(33):668-75. PMID: 11230748
57. Fisher RA, editor. Statistical methods and scientific inference. New York: Hafner Publishing Co; 1959.
58. Szabo G, Velayudham A, Romics LJ, Mandrekar P. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcoholism: Clinical and Experimental Research. 2005 29:140S-5S. PMID: 16344599
59. Liu Z. The renin-angiotensin system and insulin resistance. Current Diabetes Reports. 2007; 7(1):34-42. PMID: 17254516
60. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proceedings of the National Academy of Sciences of the United States of America. 2008; 18(105):6531-6. doi: 10.1073/pnas.0802690105 PMID: 18443281
61. Panasiuk A, Dzieciol J, Panasiuk B, Prokopowicz D. Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2006 38(12):6198-202. PMID: 17036395
62. Silverman GA, editor. Ovalbumin Serpins.: John Wiley & Sons; 2005.
63. Olson JM, Hallahan AR. p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med. 2004; 3(10):125-9.
64. Baek JH, Kim J, Kang C, Lee YS, Kim KW. Induction of apoptosis by bile acids in HepG2 human hepatocellular carcinoma cells. The Korean Journal of Physiology & Pharmacology. 1997; 1:107-15. PMID: 14766936
65. Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Research. 1995; 5(55):979-83. PMID: 7867007
66. Vecchini A, Ceccarelli V, Susta F, Caligiana P, Orvietani P, Binaglia L, et al. Dietary alpha-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells. Journal of Lipid Research. 2004 2(45):308-16. PMID: 14563831
67. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Molecular and Cellular Biology. 2001 21.
68. Bonzo JA, Ferry CH, Matsubara T, Kim JH, Gonzalez FJ. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice. Journal of Biological Chemistry 2012 2.
69. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology. 2004; 4(39):1038-47. PMID: 15057908
70. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Research. 2010.
71. Jackson KA, Valentine RA, Coneyworth LJ, Mathers JC, Ford D. Mechanisms of mammalian zinc-regulated gene expression. Biochem Soc Trans. 2008; 36(Pt 6):1262-6.
72. Shibata K., Kajiyama H, Yamamoto E, Terauchi M, Ino K, Nawa A, et al. Establishment and characterization of an ovarian yolk sac tumor cell line reveals possible involvement of Nkx2.5 in tumor development. Oncology. 2008 1-2(74):104-11.
73. Meligi AA, Zakaria A, Khodari MI, Khodari H. Basic fibroblast growth factor (b FGF) in hepatocellular carcinoma and benign chronic liver disease. Scientific Medical Journal. 2004; 16(4).
74. Yuan JH, Yang F, Wang FX, Ma JZ, Guo YJ, Tao QF, et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014 5(25):666-81. doi: 10.1016/j.ccr.2014.03.010 PMID: 24768205